$60.61 -0.21 (%) Bristol-Myers Squibb Co - NYSE

Aug. 28, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's M&A Chatter for Thursday August 27, 2015

    Benzinga | Aug. 27, 2015 | 19:15PM EST
  2. Allied-Bristol Life Sciences Licenses Platform Technology and Lead Molecules from Yale University

    Benzinga | Aug. 27, 2015 | 04:31AM EST
  3. Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

    GuruFocus | Aug. 11, 2015 | 11:33AM EST
  4. uniQure Receives Additional $53M from Bristol-Myers Squibb for Target Selection Payment and Additional Equity Investment

    Benzinga | Aug. 10, 2015 | 05:03AM EST
  5. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  6. Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal

    IBD | Jul. 28, 2015 | 13:03PM EST
  7. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD | Jul. 24, 2015 | 13:26PM EST
  8. Valeant Posts Princely Gains

    IBD | Jul. 23, 2015 | 18:55PM EST
  9. Bristol-Myers Q2 profit jumps

    IBD | Jul. 23, 2015 | 18:48PM EST
  10. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD | Jul. 23, 2015 | 17:50PM EST
  11. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD | Jul. 23, 2015 | 14:42PM EST
  12. Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

    IBD | Jul. 23, 2015 | 10:58AM EST
  13. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 09:37AM EST
  14. Bristol-Myers Squibb Posts Upbeat Q2 Results, Lifts Profit Forecast

    Benzinga | Jul. 23, 2015 | 09:32AM EST
  15. Stock Futures Up, But Volatile; SanDisk, Cirrus, Fortinet Soar

    IBD | Jul. 23, 2015 | 09:17AM EST
  16. US Stock Futures Rise Ahead Of General Motors, McDonald's Earnings

    Benzinga | Jul. 23, 2015 | 06:55AM EST
  17. European Medicines Agency Validates Two Parallel Type II Variation Applications to Extend the Opdivo (nivolumab) Indication in Europe

    Benzinga | Jul. 23, 2015 | 06:33AM EST
  18. Bristol Myers Announces EMA Validates Two Parallel Type II Variation Applications to Extend Opdivo Indication in Europe

    Benzinga | Jul. 23, 2015 | 06:33AM EST
  19. Earnings Scheduled For July 23, 2015

    Benzinga | Jul. 23, 2015 | 04:46AM EST
  20. Second-Generation Investigational HIV-1 Maturation Inhibitor Demonstrates Positive New Phase IIa Results, Supporting Continued Development

    Benzinga | Jul. 21, 2015 | 14:00PM EST
  21. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD | Jul. 20, 2015 | 18:50PM EST
  22. Bristol-Myers: kidney drug win

    IBD | Jul. 20, 2015 | 18:41PM EST
  23. Bristol-Myers Announces European Commission Has Approved Nivolumab BMS in Europe

    Benzinga | Jul. 20, 2015 | 12:09PM EST
  24. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD | Jul. 20, 2015 | 10:50AM EST
  25. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  26. Bristol-Myers' HIV-1 Drug Approved In Europe

    Benzinga | Jul. 16, 2015 | 12:07PM EST
  27. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  28. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  29. Fast Money Picks For July 7

    Benzinga | Jul. 7, 2015 | 06:47AM EST
  30. Biogen, AGTC Link Up To Develop Gene Therapy

    IBD | Jul. 2, 2015 | 11:28AM EST
  31. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  32. Amgen Among 3 Medical Giants With Healthy Payouts

    IBD | Jun. 30, 2015 | 18:33PM EST
  33. Will Bill Ackman Go After Express Scripts Next?

    GuruFocus | Jun. 30, 2015 | 14:55PM EST
  34. Fast Money Picks For June 30

    Benzinga | Jun. 30, 2015 | 07:23AM EST
  35. Aetna Said Close To Humana Deal; Kroger Ups Dividend

    IBD | Jun. 25, 2015 | 15:06PM EST
  36. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story

    GuruFocus | Jun. 22, 2015 | 18:34PM EST
  37. Benzinga's Top Initiations

    Benzinga | Jun. 17, 2015 | 09:29AM EST
  38. Piper Jaffray Initiates Bristol-Myers Squibb With Underperform

    Benzinga | Jun. 17, 2015 | 08:09AM EST
  39. Axovant Sciences Sets 20-Year Record For Biotech IPOs

    IBD | Jun. 11, 2015 | 16:58PM EST
  40. What We Don't Know About Antibiotics Could Kill Us

    FoxBusiness | Jun. 11, 2015 | 05:00AM EST
  41. 2 M&A Rumors Moving The Market

    Benzinga | Jun. 4, 2015 | 15:29PM EST
  42. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  43. Stocks Protect Solid Gains; Bullish Setup For Zebra Technologies

    IBD | Jun. 1, 2015 | 15:10PM EST
  44. Stocks Eke Out Narrow Gains; eBay Breakout Gains Traction

    IBD | Jun. 1, 2015 | 13:26PM EST
  45. Options Outlook: Market Switches From 'Headline' To 'Sentiment' Mode

    Benzinga | Jun. 1, 2015 | 12:59PM EST
  46. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  47. Stocks Step Out To Mixed Start; Bristol Myers Rises, Wynn Fades

    IBD | Jun. 1, 2015 | 10:37AM EST
  48. Bristol Dives On Cancer Drug

    IBD | May. 29, 2015 | 18:43PM EST
  49. Stocks End On A Downer; Oil Jumps, Selling Resumes In Chipotle

    IBD | May. 29, 2015 | 16:24PM EST
  50. Bristol Sinks On Lung Cancer Data; Merck Up On 2 Trials

    IBD | May. 29, 2015 | 16:22PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!